Inogen Inc (INGN) stock
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.57−0.11 (-2.02%)
Close on Nov 18, 2026Market cap $147.82MP/E –Yield –
Inogen revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Inogen's revenue for the twelve months ending Jun 30, 2026 was $354.30M, up 3.2% year over year. For fiscal 2025 it was $348.67M, up 3.9% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $377.24M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $348.67M | +3.9% |
| FY2024 | Dec 31, 2024 | $335.71M | +6.4% |
| FY2023 | Dec 31, 2023 | $315.66M | -16.3% |
| FY2022 | Dec 31, 2022 | $377.24M | +5.4% |
| FY2021 | Dec 31, 2021 | $358.00M | +16.1% |
| FY2020 | Dec 31, 2020 | $308.49M | -14.8% |
| FY2019 | Dec 31, 2019 | $361.94M | +1.1% |
| FY2018 | Dec 31, 2018 | $358.11M | +43.6% |
| FY2017 | Dec 31, 2017 | $249.44M | +23.0% |
| FY2016 | Dec 31, 2016 | $202.83M | +27.6% |
| FY2015 | Dec 31, 2015 | $159.01M | +41.3% |
| FY2014 | Dec 31, 2014 | $112.54M | +49.2% |
| FY2013 | Dec 31, 2013 | $75.44M | +55.3% |
| FY2012 | Dec 31, 2012 | $48.58M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $95.08M | +3.0% |
| Q1 FY2026 | Mar 31, 2026 | $85.11M | +3.4% |
| Q4 FY2025 | Dec 31, 2025 | $81.72M | +2.0% |
| Q3 FY2025 | Sep 30, 2025 | $92.39M | +4.0% |
| Q2 FY2025 | Jun 30, 2025 | $92.28M | +4.0% |
| Q1 FY2025 | Mar 31, 2025 | $82.28M | +5.5% |
| Q4 FY2024 | Dec 31, 2024 | $80.08M | +5.5% |
| Q3 FY2024 | Sep 30, 2024 | $88.83M | +5.8% |
| Q2 FY2024 | Jun 30, 2024 | $88.77M | +6.1% |
| Q1 FY2024 | Mar 31, 2024 | $78.03M | +8.1% |
| Q4 FY2023 | Dec 31, 2023 | $75.90M | -13.8% |
| Q3 FY2023 | Sep 30, 2023 | $83.97M | -20.3% |
| Q2 FY2023 | Jun 30, 2023 | $83.64M | -19.1% |
| Q1 FY2023 | Mar 31, 2023 | $72.16M | -10.2% |
| Q4 FY2022 | Dec 31, 2022 | $88.09M | +15.3% |
| Q3 FY2022 | Sep 30, 2022 | $105.39M | +13.2% |
| Q2 FY2022 | Jun 30, 2022 | $103.38M | +1.8% |
| Q1 FY2022 | Mar 31, 2022 | $80.39M | -7.5% |
| Q4 FY2021 | Dec 31, 2021 | $76.40M | +3.3% |
| Q3 FY2021 | Sep 30, 2021 | $93.11M | +25.3% |
| Q2 FY2021 | Jun 30, 2021 | $101.56M | +41.7% |
| Q1 FY2021 | Mar 31, 2021 | $86.93M | -1.8% |
| Q4 FY2020 | Dec 31, 2020 | $73.98M | -6.3% |
| Q3 FY2020 | Sep 30, 2020 | $74.33M | -19.0% |
| Q2 FY2020 | Jun 30, 2020 | $71.69M | -29.1% |
| Q1 FY2020 | Mar 31, 2020 | $88.49M | -1.9% |
| Q4 FY2019 | Dec 31, 2019 | $78.92M | -8.8% |
| Q3 FY2019 | Sep 30, 2019 | $91.76M | -3.7% |
| Q2 FY2019 | Jun 30, 2019 | $101.06M | +3.9% |
| Q1 FY2019 | Mar 31, 2019 | $90.20M | +14.1% |
| Q4 FY2018 | Dec 31, 2018 | $86.53M | +35.7% |
| Q3 FY2018 | Sep 30, 2018 | $95.29M | +38.0% |
| Q2 FY2018 | Jun 30, 2018 | $97.24M | +51.6% |
| Q1 FY2018 | Mar 31, 2018 | $79.05M | +50.6% |
| Q4 FY2017 | Dec 31, 2017 | $63.79M | +25.4% |
| Q3 FY2017 | Sep 30, 2017 | $69.03M | +26.8% |
| Q2 FY2017 | Jun 30, 2017 | $64.12M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $50.85M | – |
| Q3 FY2016 | Sep 30, 2016 | $54.42M | – |
See a number that looks wrong?